✦ LIBER ✦

Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial

✍ Scribed by Basch, Ethan; Autio, Karen; Ryan, Charles J; Mulders, Peter; Shore, Neal; Kheoh, Thian; Fizazi, Karim; Logothetis, Christopher J; Rathkopf, Dana; Smith, Matthew R; Mainwaring, Paul N; Hao, Yanni; Griffin, Thomas; Li, Susan; Meyers, Michael L; Molina, Arturo; Cleeland, Charles

Book ID: 121652568
Publisher: The Lancet
Year: 2013
Tongue: English
Weight: 231 KB
Volume: 14
Category: Article
ISSN: 1470-2045
DOI: 10.1016/S1470-2045(13)70424-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aflibercept versus placebo in combinatio

Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial

✍ Tannock, Ian F; Fizazi, Karim; Ivanov, Sergey; Karlsson, Camilla Thellenberg; Fl 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 310 KB

Re: Aflibercept versus Placebo in Combin

Re: Aflibercept versus Placebo in Combination with Docetaxel and Prednisone for Treatment of Men with Metastatic Castration-Resistant Prostate Cancer (VENICE): A Phase 3, Double-Blind Randomised Trial

✍ Taneja, Samir S. 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 59 KB

7000 ORAL Final Overall Survival (OS) An

7000 ORAL Final Overall Survival (OS) Analysis of COU-AA-301, a Phase 3 Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Pretreated With Docetaxel

✍ Fizazi, K.; Scher, H.I.; Molina, A.; Logothetis, C.J.; Jones, R.J.; Staffurth, J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

127 Improved survival in elderly (≥75 yr

127 Improved survival in elderly (≥75 yr) metastatic castration-resistant prostate cancer (mCRPC) patients upon treatment with abiraterone acetate (AA) plus prednisone (P) progressing after docetaxel-based chemotherapy: Results from COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study

✍ P.F.A. Mulders; A. Molina; M. Marberger; F. Saad; J.H. Li; T. Kheoh; C.M. Haqq; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB